Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Kinetic Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104178548A details high-purity S-2-naphthylethylamine synthesis via lipase. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Novel dynamic kinetic resolution method for R-2-naphthylethylamine. High yield, 99% ee. Cost-effective nickel catalyst. Reliable supply chain partner.
Patent CN104152525A reveals dynamic kinetic resolution for R-1-phenylethylamine. Achieve high yield and purity with cost-effective Raney nickel catalysts for supply chain stability.
Patent CN104178546A details high-yield enzymatic resolution for S-1-naphthylethylamine. Offers superior purity and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN102277392B details enzymatic resolution for high-purity pharmaceutical intermediates. Offers significant cost reduction and supply chain reliability for global buyers.
Patent CN104164470B details a novel DKR method for R-1-naphthylethylamine using Raney Nickel. This approach ensures high yield and purity for reliable pharmaceutical intermediates supply chains.
Patent CN104151171B details nickel-catalyzed dynamic kinetic resolution for high yield chiral amine production ensuring supply chain stability and cost efficiency.
Patent CN1115343C details a novel enzymatic route for chiral cyclopentene amines, offering cost-effective API intermediate manufacturing with high enantiomeric purity.
Patent CN105017035B details a high-purity DKR method for chiral intermediates. Achieves >99% ee with scalable catalysts for reliable pharmaceutical supply chains.
Patent CN104263796A details a high-yield chiral synthesis route. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN104557911B reveals enzymatic deracemization for levo-praziquantel. Achieve high optical purity and cost reduction in pharmaceutical intermediates manufacturing with scalable green chemistry.
Patent CN117105887A reveals a novel Salen Co-catalyzed resolution for chiral epichlorohydrin. Achieve high purity, catalyst recycling, and significant cost reduction in pharmaceutical manufacturing.
Patent CN103288630A details a novel synthesis of Sodium Danshensu from L-Tyrosine. This report analyzes the DKR strategy for cost-effective, high-purity API intermediate manufacturing.
Patent CN103820416B reveals high-stereoselectivity ester hydrolase for chiral synthesis. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101270112A details a polymeric Schiff base-metal complex for high-ee cyclic carbonates, offering superior recyclability and cost efficiency for pharma intermediates.
Advanced Salen-catalyzed kinetic resolution process for high-purity statin intermediates. Delivers cost reduction in API manufacturing and reliable supply chain continuity.
Patent CN101735085A details a high-yield D-serine synthesis using dynamic kinetic resolution, offering significant cost reduction and supply stability for pharmaceutical intermediates.
Patent CN112538033A details a Pd-catalyzed kinetic resolution method yielding high-purity chiral cyclophanes with superior enantioselectivity and scalability.
Patent CN101314559B details a low-cost kinetic resolution method for aromatic chiral secondary alcohols using Boc-Proline, offering high purity for pharma intermediates.
Patent CN109761984B details a novel ruthenium-catalyzed asymmetric hydrogen transfer method for synthesizing chiral purine nucleosides with high enantioselectivity and mild conditions.